Bio-Techne
TECH
$77.19
Share price
-0.08%
Change (1 day)
-5.51%
Change (1 year)
Categories
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.
Bio-Techne (TECH) - Cash on Hand
Cash on Hand as of March 2024 : $0.14 B
According to Bio-Techne's latest financial reports the company has $0.14 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Bio-Techne - Cash on Hand chart (from 2001 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-06-30 | $0.20 B | -17.29% |
| 2022-06-30 | $0.24 B | 6.68% |
| 2021-06-30 | $0.23 B | -14.52% |
| 2020-06-30 | $0.27 B | 63.16% |
| 2019-06-30 | $0.16 B | -8.65% |
| 2018-06-30 | $0.18 B | 15.24% |
| 2017-06-30 | $0.15 B | 64.57% |
| 2016-06-30 | $95.83 M | -13.6% |
| 2015-06-30 | $0.11 B | -69.47% |
| 2014-06-30 | $0.36 B | 9.14% |
| 2013-06-30 | $0.33 B | 23.77% |
| 2012-06-30 | $0.26 B | 91.02% |
| 2011-06-30 | $0.14 B | 1.44% |
| 2010-06-30 | $0.13 B | -31.58% |
| 2009-06-30 | $0.20 B | -1.68% |
| 2008-06-30 | $0.20 B | 25.23% |
| 2007-06-30 | $0.16 B | 51.38% |
| 2006-06-30 | $0.10 B | 12.06% |
| 2005-06-30 | $97.13 M | 3.63% |
| 2004-06-30 | $93.73 M | -20.23% |
| 2003-06-30 | $0.11 B | 21.06% |
| 2002-06-30 | $97.06 M | -0.01% |
| 2001-06-30 | $97.07 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $7.25 B | 4,889.26% | 🇺🇸 USA |
 Becton Dickinson BDX | $3.17 B | 2,084.95% | 🇺🇸 USA |
 General Electric GE | $22.18 B | 15,166.46% | 🇺🇸 USA |
 Danaher DHR | $7.03 B | 4,738.55% | 🇺🇸 USA |
 Qiagen QGEN | $0.89 B | 514.63% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | $60.24 M | -58.54% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $1.64 B | 1,032.51% | 🇺🇸 USA |